2023
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
Lee I, Okumura K, Misawa R, Sogawa H, Veillette G, John D, Diflo T, Nishida S, Dhand A. Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States. World Journal Of Hepatology 2023, 15: 554-563. PMID: 37206654, PMCID: PMC10190691, DOI: 10.4254/wjh.v15.i4.554.Peer-Reviewed Original ResearchLiver transplantationHepatocellular carcinomaUnited Network for Organ SharingAlcoholic liver diseaseGraft survivalPathological characteristics of hepatocellular carcinomaMultivariate Cox hazard regression analysisCox hazard regression analysisCharacteristics of hepatocellular carcinomaOutcome of liver transplantationDiagnosis of non-alcoholic steatohepatitisOutcomes of LTSurvival of liver transplantationUnited StatesPost-transplant mortalityField of transplantationDonor risk indexNon-alcoholic steatohepatitisLT recipientsRecipient agePostoperative outcomesInferior outcomesAdult LTRoutine medical careVascular invasionValidation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma
Miguez S, Lee R, Chan A, Demkowicz P, Jones B, Long C, Abramson D, Bosenberg M, Sznol M, Kluger H, Goldbaum M, Francis J, Pointdujour-Lim R, Bakhoum M. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma. Ophthalmology 2023, 130: 598-607. PMID: 36739981, PMCID: PMC10619207, DOI: 10.1016/j.ophtha.2023.01.020.Peer-Reviewed Original ResearchConceptsMetastasis-free survivalRisk of metastasisClass 2 tumorsAdditional prognostic valueRate of metastasisPrognostic usefulnessTumor sizeTumor characteristicsPrognostic valueUveal melanomaGene expression profile testingMemorial Sloan-Kettering Cancer CenterGEP classificationCox hazard regression analysisYale-New Haven HospitalHazards regression analysisGene expression profiling testsNew Haven HospitalClass 1 tumorsGEP class 2Class 1AMean followTumor thicknessCancer CenterSurveillance protocol
2022
Trends and outcomes of liver transplantation among older recipients in the United States
Okumura K, Lee J, Dhand A, Sogawa H, Veillette G, John D, Misawa R, Bodin R, Wolf D, Diflo T, Nishida S. Trends and outcomes of liver transplantation among older recipients in the United States. World Journal Of Transplantation 2022, 12: 259-267. PMID: 36159074, PMCID: PMC9453296, DOI: 10.5500/wjt.v12.i8.259.Peer-Reviewed Original ResearchRisk of graft failureOutcomes of LTDonor risk indexLiver transplantationHCV-positive statusBody mass indexGraft failureMedian ageMechanical ventilationPrimary etiology of liver diseasePresence of portal vein thrombosisFemale sexAverage age of recipientsLiver diseaseIncreased risk of graft failureMultivariate Cox hazard regression analysisCox hazard regression analysisRisk factorsEtiology of liver diseasePositive statusOlder groupOutcome of liver transplantationTime of LTPreoperative mechanical ventilationUnited Network for Organ Sharing databaseAssociation between enrollment in an enhanced recovery program for colorectal cancer surgery and long‐term recurrence and survival
Zorrilla‐Vaca A, Ripolles‐Melchor J, Abad‐Motos A, Mingu I, Moreno‐Jurado N, Martínez‐Durán F, Pérez‐Martínez I, Abad‐Gurumeta A, FuenMayor‐Varela M, Mena G, Grant M. Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long‐term recurrence and survival. Journal Of Surgical Oncology 2022, 125: 1269-1276. PMID: 35234283, DOI: 10.1002/jso.26836.Peer-Reviewed Original ResearchConceptsColorectal cancer surgeryCancer surgeryOncologic recurrenceColorectal cancerCancer stageCox hazard regression analysisMedian compliance rateSurgical inflammatory responseAdvanced colorectal cancerEnhanced recovery programmeOverall survival rateHazards regression analysisLong-term recurrenceAdvanced cancer stageERAS groupERAS interventionsERAS programOverall survivalMultivariable analysisSubgroup analysisInflammatory responseSurgery programLower riskEnhanced recoveryIntervention studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply